Adjunctive pharmacologic treatment for elective stenting of the extracranial carotid arteries

Abstract

Endovascular stenting of the extracranial carotid arteries is a viable treatment option to carotid endarterectomy in selected patients. Patients undergoing this procedure must be treated with aspirin 325 mg at least 24 hours prior to the procedure and clopidogrel 75 mg oral, three to five days prior to the procedure (or 300 mg at least six hours prior to stenting). During the intervention, heparin is given to maintain an activated clotting time of at least 300 seconds. Although there are theoretical advantages on the use of a platelet IIb/IIIa inhibitor, their routine use during elective carotid stenting is not recommended until their clinical benefits have been clearly demonstrated in this patient population. Hemodynamic instability during balloon inflation and stent deployment should be treated with intravenous fluids, atropine, and an alpha agonist such as neosynephrine. All the oral antihypertensive must be discontinued after the procedure and if there is persistence of hypotension making discontinuation of neosynephrine difficult, an oral alpha agonist such as midodrine (2.5 to 5 mg two to three times daily) is helpful. In the majority of patients this medication can be tapered off three to five days following stenting.

• Carotid Artery
• Stent